Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 20 de 27 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W, for the Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929-35. [Ref.ID 98367]
2. Cita con resumen
Mishra NK, Ahmed N, Andersen G, Egido JA, Linsberg PJ, Ringleb PA, Wahlgren NG, Lees KR, for the VISTA and SITS collaborators. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 2010;341:1144. [Ref.ID 89721]
3.Tiene citas relacionadas Cita con resumen
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, for the ECASS ATLANTIS NINDS and EPITHET rt-PA Study Group Investigators. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703. [Ref.ID 88503]
4.Enlace a cita original
Dawson J, Quinn TJ, Harrow C, Lees KR, Walters MR. The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial. Br J Clin Pharmacol 2009;68:662-8. [Ref.ID 87158]
5.Tiene citas relacionadas Cita con resumen
Wahlgren N, Ahmed N, Dávalos A, Hacke W, Millán M, Muir K, Roine RO, Toni D, Lees KR, for the SITS investigators. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303-9. [Ref.ID 84187]
6.Tiene citas relacionadas Cita con resumen
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29. [Ref.ID 84064]
7. Cita con resumen
Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, Diener HC, Ashwood T, Wasiewski WW, Emeribe U, for the SAINT II Trial Investigators. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007;357:562-71. [Ref.ID 80875]
8.
Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G, for the SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82. [Ref.ID 78980]
9.Tiene citas relacionadas
Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark H-G, Wasiweski WW, for the Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for acute ischemic stroke. N Engl J Med 2006;354:588-600. [Ref.ID 76140]
10.Tiene citas relacionadas Cita con resumen
Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo JM, Whitehead J, for the GAIN International Investigators. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. Lancet 2000;355:1949-54. [Ref.ID 51225]
11.
Lees KR, Bath PMW, Naylor A R. Secondary prevention of transient ischaemic attack and stroke. BMJ 2000;320:991-4. [Ref.ID 50357]
12.
Bath PMW, Lees KR. Acute stroke. BMJ 2000;320:920-3. [Ref.ID 50220]
13.Tiene citas relacionadas
Overell JR, Weir CJ, Walker A, Lees KR. Treatment and secondary prevention of stroke. Lancet 2000;355:319-20. [Ref.ID 49039]
14.
Lees KR. If I had a stroke. Lancet 1998;352:28-30. [Ref.ID 44007]
15.Tiene citas relacionadas
Lees KR. ECASS-II: intravenous alteplase in acute ischaemic stroke. Lancet 1999;353:65-6. [Ref.ID 42246]
16. Cita con resumen
Lees KR. Multifactorial approach to stroke investigation and prevention. Lancet 1998;352:923-4. [Ref.ID 41091]
17.
Lees KR. Does neuroprotection improve stroke outcome?. Lancet 1998;351:1447-8. [Ref.ID 38628]
18.Tiene citas relacionadas
Bradford APJ, Khan SA, Lees KR, McInnes GT, Semple PF. Interpretation of IST and CAST stroke trials. Lancet 1997;350:440-1. [Ref.ID 35205]
19.
Lees KR, Reid J L. Adverse event with first-dose perindopril in congestive heart failure. Lancet 1997;350:520. [Ref.ID 35030]
20. Cita con resumen
Dyker AG, Weir CJ, Lees KR. Influence of cholesterol on survival after stroke: retrospective study. BMJ 1997;314:1584-8. [Ref.ID 32549]
Seleccionar todas
 
 1 a 20 de 27 siguiente >>